 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
|
|
|
|
Phase III
|
|
|
|
CALGB-80101
NCCTG-CALGB-80101, ECOG-CALGB-80101, CALGB-80101, NCT00052910
|
|
| |
Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer
|
|
|
|
Phase II, Phase I
|
|
|
|
Pro00002207
SPS 151596, NCT00578071
|
|
| |
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
|
|
|
|
Phase II
|
|
|
|
CINJ-3330
NCT00161187
|
|
| |
Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001
|
|
|
|
Phase II
|
|
|
|
BrUOG-E-215
NCT00522795
|
|
| |
Phase II Study of Imatinib and Pegylated Interferon-a 2B in Imatinib-naïve GIST Patients
|
|
|
|
Phase II
|
|
|
|
HCI 22172
IRB#: 00022172, NCT00585221
|
|
| |
Pre-Operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma
|
|
|
|
Phase II
|
|
|
|
08-081
NCT00737438
|
|
| |
Chemoradiation-Induced Nausea and Emesis: Quality of Life
|
|
|
|
No phase specified
|
|
|
|
2003-0529
NCT00394602
|
|
| |
Respiratory Tumor and Normal Tissue Motion
|
|
|
|
No phase specified
|
|
|
|
2003-0962
NCT00415675
|
|
| |
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder
|
|
|
|
No phase specified
|
|
|
|
CCCWFU-99B98
CCCWFU 99B98, CCCWFU-BG99-047, NCT00489515
|
|
| |
Intraoperative Cell Saver Autotransfusion Use for Major Surgical Oncology Operations.
|
|
|
|
No phase specified
|
|
|
|
Cell Saver 704.03
NCT00708513
|
|
